F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.54 EUR 2.67% Market Closed
Market Cap: 570.4m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Fluidigm Corp
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fluidigm Corp
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluidigm Corp
F:FLB
Total Current Assets
$480m
CAGR 3-Years
83%
CAGR 5-Years
35%
CAGR 10-Years
14%
Thermo Fisher Scientific Inc
NYSE:TMO
Total Current Assets
$23.8B
CAGR 3-Years
-1%
CAGR 5-Years
18%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Total Current Assets
$10.1B
CAGR 3-Years
-2%
CAGR 5-Years
-13%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Total Current Assets
$1.2B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
3%
Agilent Technologies Inc
NYSE:A
Total Current Assets
$4.3B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
-1%
IQVIA Holdings Inc
NYSE:IQV
Total Current Assets
$5.6B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
11%
No Stocks Found

Fluidigm Corp
Glance View

Market Cap
569.7m EUR
Industry
Life Sciences Tools & Services

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
1.08 EUR
Overvaluation 30%
Intrinsic Value
Price
F

See Also

What is Fluidigm Corp's Total Current Assets?
Total Current Assets
480m USD

Based on the financial report for Jun 30, 2024, Fluidigm Corp's Total Current Assets amounts to 480m USD.

What is Fluidigm Corp's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
14%

Over the last year, the Total Current Assets growth was 162%. The average annual Total Current Assets growth rates for Fluidigm Corp have been 83% over the past three years , 35% over the past five years , and 14% over the past ten years .

Back to Top